The First-Ever Lab-Grown ‘Pigmented’ Skin-Equivalent Has Been Developed

Cutting-edge new research models delivering a new concept to diversity in skincare research and development.

With recent developments of Artificial-Intelligence (AI) and new discoveries in biological research, the science field is undoubtedly exploding with new research findings. One recent release in particular comes from the likes of LabSkin, a service provider of human skin microbiology services to support product research and development activities in the cosmeceutical and pharmaceutical sector. LabSkin have developed an innovative first-ever lab-grown pigmented skin-equivalent model, for research into skin health and the development of skincare products.

“Our skin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function.”

LabSkin
Pictured below from left to right: Dr Sobia Kauser, Assistant Professor University of Bradford, Dr. David Caballero-Lima, Chief Scientist Labskin, Dr. Jacobo Elies Gomez, Assistant Professor, University of Bradford, Dr. Omera Bi, Labskin

Developed over 12 years with more than 30 scientific journal publications, it is made from young keratinocytes (human skin cells) and adult fibroblasts (metabolically-active, collagen-producing human skin cells). This allows for the facilitation of high quality skin research and tests available commercially for research and development.

What is incredibly fascinating is that the LabSkin team of researchers that developed these new ‘pigmented’ models incorporating melanocytes allow them to further assess safety and efficacy of skincare ingredients and formulations on a greater diversity of skin types, integrating ethnic skin with various microbiomes.

“The presence of melanocytes on the skin model also permits the study of causes and alleviation of hyperpigmentation, creates an ideal model to study UV exposure response and phototoxicity, and opens the door to establish reproducible melanoma models for the pharmaceutical industry.”

LabSkin

Dr David Caballero-Lima, Chief Scientist at Labskin, concludes: “This new model is allowing us and our clients to get a deeper understanding about melanin production in healthy and pathological stages, skin toxicology, drug metabolism and the host microbe interaction. It’s a critical development for the cosmetics and dermatological sectors to provide even more precise testing platforms to deliver first class, safe and efficacious products.”

Read SPA+CLINIC’s latest issue here:

There are 5 ways you can catch up with SPA+CLINIC

  1. Our quarterly print magazine, delivered to your door. Subscribe here.
  2. Our website, which is updated daily with its own completely unique content and breaking news.
  3. Our weekly newsletter – free to your inbox! Subscribe here.
  4. Our digital magazine – click here to view previous issues.
  5. Our social media – see daily updates on our InstagramFacebook Linkedin

Recommended Articles

SHORTLIST 0